Apr 23, 2020
Study Underway to Examine the Planned Use of Voraxaze® with Methotrexate in CNS Lymphoma
Mar 12, 2020
AbbVie Receives European Commission Approval of VENCLYXTO® Combination Regimen for Patients with Previously-Untreated Chronic Lymphocytic Leukemia
Mar 04, 2020
Alopexx Oncology Announces Licensing Agreement with Beijing Shenogen Pharma Group for Development and Commercialization of Novel Immunocytokine for the Treatment of B-Cell Lymphomas in China/Asia
Nov 06, 2019
Henlius HLX01 (Rituximab Injection) Wins "Biosimilar Initiative of the Year" at Global Generics & Biosimilars Awards 2019
Nov 04, 2019
Ascentage Pharma and Henlius Form a Combination Therapy Strategic Collaboration
Oct 21, 2019
Sjogren's Syndrome (SS) Market Insights, Epidemiology and Market Forecast, 2028
Sep 27, 2019
FDA approves first treatment for children with rare diseases that cause inflammation of small blood vessels
Sep 20, 2019
Innovent Provides Update on Two Studies of IBI301 (Rituximab Biosimilar) in the Treatment of CD20-positive Lymphoma at Annual Meeting of CSCO
Aug 22, 2019
Amgen And Allergan Announce Positive Top-Line Results From Comparative Clinical Study Of ABP 798, Biosimilar Candidate To Rituxan® (Rituximab)
Aug 12, 2019
Medicines targeting multiple sclerosis and lymphoma are among new specialty drugs available through AllianceRx Walgreens Prime
Jul 12, 2019
Arzerra Drug Overview 2019: A Fully Human Immunoglobulin G1 and High-Affinity Antibody that Targets a Novel Epitope on Cluster of Differentiation 20 (CD20) on the B-Cell Membrane
Jul 12, 2019
Rituxan (rituximab; Biogen/Roche/Chugai/Zenyaku Kogyo) Drug Overview & Product Profiles 2016-2026
Jul 11, 2019
Non-Hodgkin Lymphoma (NHL) Therapeutics Market to Record a CAGR of 7.4% During 2019-2024
Jun 27, 2019
NMPA Accepts New Drug Application for IBI301, a Biosimilar Product Candidate of Rituximab (MabThera/Rituxan)
Jun 03, 2019
MEI Pharma Presents Updated Clinical Data from the ME-401 Monotherapy and in Combination with Rituximab Phase 1b study in Patients with Follicular Lymphoma at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
May 30, 2019
Rare Disease Patient Candace Lerman Calls for Clinical Trials on Off-Label Treatments; Launches ITP Patient Driven Research Initiative
May 21, 2019
Nordic Nanovector: Archer-1 Phase 1b Betalutin®/Rituximab Combination Trial Advances to Next Cohort
May 07, 2019
Two Clinical Studies with IBI301, a Biosimilar Candidate to Rituximab, Met Primary Endpoints
Mar 26, 2019
Hansa Biopharma Receives Ethics and Regulatory Clearance to Start Phase 2 Study of Imlifidase in Acute Antibody Mediated Rejection in Kidney Transplantation
Mar 06, 2019
Reducing B Cells with Modified CAR T Cells is an Effective Treatment of Experimental Lupus